Johnson & Johnson

JOHNSON & JOHNSON NEWSROOM (28 press releases)

Advanced Filtering & Sorting Options:

One Click LCA expands global sustainability reach by joining with SimaPro and PRé Sustainability to create the largest LCA platform

PRESS RELEASE -- 3, September 2025

(IN BRIEF) One Click LCA has integrated SimaPro and PRé Sustainability into its operations, forming the world’s largest and most advanced life-cycle assessment (LCA) platform. With over 500,000 datasets across multiple industries, the combined platform blends SimaPro’s scientific rigor with … Read the full press release

EIB and Leyden Labs Secure €20 Million Financing to Advance Pandemic Preparedness with Innovative Nasal Spray

PRESS RELEASE -- 3, June 2025

(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million financing deal with Leyden Laboratories to support the development of its innovative pan-influenza nasal spray, which aims to protect against seasonal and pandemic viral infections. The funding, guaranteed … Read the full press release

Patients as Partners® Europe Launches the 9th Annual Event with 2025 Keynotes, Featured Speakers and Topics

PRESS RELEASE -- 11, February 2025

(IN BRIEF) The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel in London. This event offers a platform for pharma R&D and patient advocacy to discuss … Read the full press release

ETH Zurich and University of St.Gallen Launch Manufacturing Alliance to Drive Innovation and Talent Development

PRESS RELEASE -- 3, February 2025

(IN BRIEF) The University of St.Gallen and ETH Zurich have partnered to establish the “ETH-HSG Manufacturing Alliance,” aimed at boosting the competitiveness of Swiss industry and nurturing young talent. The alliance is supported by 13 leading industrial partners, including Roche, … Read the full press release

Fresenius Kabi and Formycon Receive European Approval for Ustekinumab Biosimilar FYB202

PRESS RELEASE -- 27, September 2024

(IN BRIEF) Fresenius Kabi, in collaboration with Formycon, has received approval from the European Commission (EC) for FYB202, a biosimilar of ustekinumab (marketed as Stelara® by Johnson & Johnson). This biosimilar is approved for the treatment of serious inflammatory diseases. … Read the full press release

Fresenius Kabi’s Ustekinumab Biosimilar Otulfi® Secures European Approval for Treating Inflammatory Diseases

PRESS RELEASE -- 27, September 2024

(IN BRIEF) Fresenius Kabi, in partnership with Formycon AG, has received European Commission approval for Otulfi®, a biosimilar of ustekinumab. This new product, authorized for both subcutaneous and intravenous formulations, will treat inflammatory conditions such as Crohn’s disease, plaque psoriasis, … Read the full press release

ViiV Healthcare Receives Chinese Approval for Long-Acting HIV Treatment Vocabria and Rekambys

PRESS RELEASE -- 27, October 2023

(IN BRIEF) ViiV Healthcare has received approval from China’s National Medical Products Administration (NMPA) for Vocabria (cabotegravir) in combination with Rekambys (rilpivirine), marking the first complete long-acting HIV-1 injectable treatment in China. This approval allows people living with HIV in … Read the full press release

Sanofi Collaborates with Janssen on Vaccine for Extraintestinal Pathogenic E. coli

PRESS RELEASE -- 4, October 2023

(IN BRIEF) Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize a vaccine candidate for extraintestinal pathogenic E. coli (ExPEC) that is currently in Phase 3 of clinical trials. ExPEC … Read the full press release

Barry Callebaut Group announces new CEO, Peter Feld

PRESS RELEASE -- 6, April 2023

(IN BRIEF) Barry Callebaut Group, the world’s leading manufacturer of high-quality chocolate and cocoa products, has appointed Peter Feld as its new Chief Executive Officer, effective immediately. Feld succeeds Peter Boone, who is stepping down for personal reasons. Feld has … Read the full press release

Patients and R&D Leaders Jointly Present at EU Conference on Progress with Patient-Input to Transform Medicine Development

PRESS RELEASE -- 5, January 2022

(PRESS RELEASE) New York, NY, United States, 5-Jan-2022 — /EuropaWire/ — The Conference Forum announced the launch of the 6th annual EU Patients as Partners in Medicines Development conference to take place virtually on January 24-25th, 2022 GMT time. ​​This … Read the full press release

Enel Green Power España to supply 270 GWh/year renewable power to Johnson & Johnson

PRESS RELEASE -- 13, July 2021

Enel Green Power España, has signed a 10-year Pan-European Virtual Power Purchase Agreement (VPPA) with Johnson & Johnson for the supply of 270 GWh/year of renewable power, starting in January 2023 The power supply will be produced by a hybrid … Read the full press release

Streamlining adoption of high-speed and high-resolution surface texturing delivered with the Prometheus project

PRESS RELEASE -- 4, April 2019

This three-year program brings together leading research and industrial organizations to allow the broad manufacturing of materials with low-friction, oleophobic and hydrophobic properties (PRESS RELEASE) PORTO SALVO, 4-Apr-2019 — /EuropaWire/ — Prometheus’ project will bridge the existing gap between niche … Read the full press release

Wellcome supports rapid response to the new Ebola outbreak in Congo with initial fund of up to £2 million

PRESS RELEASE -- 14, May 2018

LONDON, 14-May-2018 — /EuropaWire/ — Wellcome is making an initial fund of up to £2 million available to support a rapid response to the new Ebola outbreak in the Democratic Republic of Congo (DRC). The pledge comes after the DRC … Read the full press release

Investor AB: Patricia Industries to acquire Sarnova Holdings, Inc.

PRESS RELEASE -- 13, March 2018

STOCKHOLM, 13-Mar-2018 — /EuropaWire/ — Patricia Industries, a part of Investor AB, has signed an agreement with Water Street Healthcare Partners and Sarnova founder Matthew D. Walter to acquire Sarnova Holdings, Inc., the leading U.S. specialty distributor of healthcare products in … Read the full press release

Leadership changes at SAP SE will greatly advance its leadership pursuits in the areas of procurement, customer engagement and commerce

PRESS RELEASE -- 9, January 2018

WALLDORF, 09-Jan-2018 — /EuropaWire/ — SAP SE (NYSE: SAP) today (January 4, 2018) announced the appointments of Alex Atzberger as president of SAP Hybris and Barry Padgett as president of SAP Ariba. SAP Hybris solutions comprise the omnichannel customer engagement and commerce … Read the full press release

Changes to Actelion’s executive team to take effect upon closing of the transaction with Johnson & Johnson

PRESS RELEASE -- 17, May 2017

ALLSCHWIL/BASEL, SWITZERLAND, 17-May-2017 — /EuropaWire/ — Actelion Ltd (SIX: ATLN) today announced changes to its executive team that would only take effect upon closing of the transaction with Johnson & Johnson expected towards the end of the second quarter 2017. … Read the full press release

Johnson & Johnson to acquire all of the outstanding shares of Actelion for $280 per share payable in U.S. dollars

PRESS RELEASE -- 26, January 2017

In the previous press release the companies omitted the cash amount with which R&D NewCo will launch. This has now been rectified and noted as CHF 1 billion. Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash Tender Offer to … Read the full press release

Russian Ambassador to UK Alexander Vladimirovich Yakovenko met Igor Bobachev, EVP, IT Cluster Skolkovo Foundation at Russian embassy in the UK

PRESS RELEASE -- 10, June 2016

Alexander Vladimirovich Yakovenko, Ambassador Extraordinary and Plenipotentiary of the Russian Federation, met the head of the Russian hi-tech mission to the UK Igor Bogachev, Vice President, Executive Director of IT Cluster, Skolkovo Foundation. LONDON, 10-Jun-2016 — /EuropaWire/ — Skolkovo brings top … Read the full press release

Bayer Group sales in 2015 reached the highest level in the company’s history

PRESS RELEASE -- 26, February 2016

Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement / Group … Read the full press release

University College London part of consortium for the creation of the Apollo Therapeutics Fund

PRESS RELEASE -- 26, January 2016

LONDON, 26-Jan-2016 — /EuropaWire/ — Three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation) and the technology transfer offices of three world-leading universities (Imperial College London, University of Cambridge and UCL) have joined forces with a combined £40 million to … Read the full press release